Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Broadly Cross-Reactive HIV-1 Neutralizing Human Monoclonal Antibodies

  • Read more about Broadly Cross-Reactive HIV-1 Neutralizing Human Monoclonal Antibodies
US Application 60/623,394
Filed on 2004-10-29

Methods of Reducing the Activity of and Reducing the Concentration of an Eph Receptor Tyrosine Kinase

  • Read more about Methods of Reducing the Activity of and Reducing the Concentration of an Eph Receptor Tyrosine Kinase
US Application 60/591,986
Filed on 2004-07-29

DNA-Based Vaccination of Retroviral-Infected Individuals Undergoing Treatment

  • Read more about DNA-Based Vaccination of Retroviral-Infected Individuals Undergoing Treatment
US Application 60/586,539
Filed on 2004-07-09

A Novel Antiproliferative Factor And Methods Of Use In Interstitial Cystitis

  • Read more about A Novel Antiproliferative Factor And Methods Of Use In Interstitial Cystitis
US Application 60/569,363
Filed on 2004-05-08

COMPLETE CHARACTERIZATION AOF AN ANTIPROLIFERATIVE FACTOR FROM BLADDER EPITHELIAL CELLS OF INTERSTITIAL CYSTITIS PATIENTS

  • Read more about COMPLETE CHARACTERIZATION AOF AN ANTIPROLIFERATIVE FACTOR FROM BLADDER EPITHELIAL CELLS OF INTERSTITIAL CYSTITIS PATIENTS
US Application 60/515,850
Filed on 2003-10-30

The UBE2G2 Binding Domain in the Ubiquitin Ligase GP78 and Methods of Use Thereof

  • Read more about The UBE2G2 Binding Domain in the Ubiquitin Ligase GP78 and Methods of Use Thereof
US Application 60/583,263
Filed on 2004-06-26

Live Microbial Microbicides

  • Read more about Live Microbial Microbicides
US Application 60/604,051
Filed on 2004-08-25

Vaccines and Methods for Prevent and Treatment of Drug Resistance HIV-1 and Hepatitis B Virus

  • Read more about Vaccines and Methods for Prevent and Treatment of Drug Resistance HIV-1 and Hepatitis B Virus
US Application 60/655,984
Filed on 2005-02-22

Metastasis Suppressor Gene On Human Chromosome 8 and Its use in the Diagnosis, Prognosis and Treatment of Cancer

  • Read more about Metastasis Suppressor Gene On Human Chromosome 8 and Its use in the Diagnosis, Prognosis and Treatment of Cancer
US Application 60/591,028
Filed on 2004-07-26

Improved Replication-Competent Adenoviral Vectors

  • Read more about Improved Replication-Competent Adenoviral Vectors
US Application 60/629,722
Filed on 2004-11-18

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 127
  • Page 128
  • Page 129
  • Page 130
  • Page 131
  • Page 132
  • Page 133
  • Page 134
  • Page 135
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health